These final results, along with a previous report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two guidance the strategy of concentrating on ACKR3 as a novel way to modulate the opioid program, which could open up new therapeutic avenues for opi